WillItSurvive
Retail and consumer conglomerates · Japan

Shiseido Company

shiseidogroup.com ↗

Japanese skincare and cosmetics giant with 150+ years of R&D behind brands like Shiseido, NARS, and Drunk Elephant.

Losing its protection
Assessed 25 July 2026 · Evidence as of 25 July 2026
The structural protection is eroding.
On the recordSince 25 July 2026 · Checkable from August 2026 · Every call on the record Checkpoint: Q1 FY2026 sales results, first test of the ¥990B guidance
The call

Shiseido's science and brand history keep it alive, but L'Oréal is pulling ahead in sales growth and dealmaking while Drunk Elephant drags on results.

Shiseido makes skincare, makeup, and fragrance products sold globally, with especially strong brands in Japan and Asia. The company has real advantages that are hard to copy: 150 years of skin science research, regulatory approvals in dozens of countries, and deep customer loyalty in Asia. However, L'Oréal is growing while Shiseido is shrinking, L'Oréal makes twice the profit margin, and Shiseido's recent purchase of Drunk Elephant lost 65 percent of its value and may need to be written down. The one thing that could matter most is whether Shiseido can hit its sales targets in the next few quarters without taking heavy losses on Drunk Elephant or getting bought by a larger company.

Why
01
AI pressure: AI skin-diagnostic and personalization tools (Perfect Corp's YouCam, L'Oréal's Perso). AI apps that scan skin and recommend formulas let smaller, cheaper brands mimic Shiseido's science-backed personalization pitch. Could AI do the core job? Unlikely.
02
Bigger players: L'Oréal. L'Oréal grew sales in 2025 while Shiseido's fell about 2%, and L'Oréal just spent €4B buying Kering's fragrance brands to widen the gap. Could a giant copy it? Probably.
03
What protects it. 150 years of proprietary skin-science data, Japanese regulatory relationships, and strong brand equity across Japan and Asia Pacific.
What would change this call
Shiseido Q1-Q2 2026 sales vs FY2026 guidance of Y990B (+2% YoY). Shows whether revenue stabilization is real or just cost-cutting driven profit gains.
Announcement of Drunk Elephant impairment, write-down, or divestment. Indicates whether the Americas turnaround failed and losses are being crystallized.
Further headcount cuts in Shiseido Americas beyond the ~300 already announced. Would confirm continued deterioration in the US business rather than stabilization.
Key numbers
  • FY2025 net sales ¥970B, down about 2% YoY (2025-12-31)
  • FY2026 guidance calls for ¥990B, up 2% YoY (2026-02-10)
  • Drunk Elephant sales fell about 65% YoY in Q1 2025 (2025-Q1)
Named risks
  • Drunk Elephant continued collapse (-65% YoY Q1 2025, near -50% full-year) risks further impairment. Severity: high
  • Thin core operating margin near 7% versus L'Oréal's roughly 20% limits competitive reinvestment. Severity: high
  • Ongoing Americas layoffs and restructuring could deepen if FY2026 sales guidance is missed. Severity: medium
  • China and Asia Pacific exposure to geopolitical boycotts, as seen in the 2023 Fukushima-linked 14% stock drop. Severity: medium
  • Industry consolidation (L'Oréal-Kering, Estee Lauder-Puig talks) could leave mid-size Shiseido strategically squeezed. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
L'Oréalgaining onGrew revenue in 2025 while Shiseido fell 2.1%; bought Kering beauty for €4B, 2025/2026
Puiggaining onOne of only three major beauty groups (with L'Oréal, Amorepacific) to grow revenue in 2025
Amorepacificgaining onGrew revenue in 2025 while Shiseido's sales declined, per 2026-06-28 industry report
Estee LaudercontestingAlso restructuring heavily, cut 7,000+ jobs in February 2025 amid shared prestige-beauty slowdown
CotycontestingCut about 700 jobs globally in 2025 amid similar fragrance/mass-prestige headwinds
Questions people ask
Is Shiseido profitable in 2026?
Yes, Shiseido projects FY2026 core operating profit to rise 55% to ¥69 billion (7.0% margin) and EBITDA of ¥119 billion, per its February 10, 2026 results presentation, though margins remain far below rival L'Oréal's roughly 20%.
Is Shiseido losing market share to L'Oréal?
Yes. Shiseido's sales fell about 2.1% in 2025 while L'Oréal grew and spent €4 billion acquiring Kering's beauty division (Creed, Gucci, Bottega Veneta fragrance) in 2025/2026, widening the scale gap between the two.
Is Shiseido doing layoffs?
Yes. Shiseido Americas cut roughly 300 jobs, over 15% of its US workforce, in mid-2025 amid the Drunk Elephant sales collapse, while total headcount fell from 27,908 in 2024 to 26,330 in 2025.
Could AI replace Shiseido?
Unlikely to replace it outright. Shiseido holds over 150 years of proprietary skin-science data, regulatory approvals and physical distribution that AI can't replicate, though rivals like L'Oréal's AI-driven Cell BioPrint (CES 2025) pressure its personalization edge.
What happened to Shiseido's Drunk Elephant brand?
Drunk Elephant, bought for $845 million in 2019/2020, fell about 65% YoY in Q1 2025 and contracted nearly 50% across full-year 2025, triggering significant Shiseido Americas layoffs announced July 18, 2025.
Who owns Shiseido?
Shiseido is an independent public company listed on the Tokyo Stock Exchange (ticker 4911), a Nikkei 225 constituent, with no parent company; its market capitalization was about ¥1.22 trillion as of July 25, 2026.
Timeline
  • 2026-02-10FY2025 results: net sales ¥970B (-2% YoY), stock fell 2.64% despite profit beat
  • 2025-11-10Unveiled 2030 Medium-Term Strategy, closed APAC and Korea Innovation Centers
  • 2025-08-10Reported roughly 300 US job cuts at Shiseido Americas
  • 2025-08-061H2025 results: net sales ¥469.8B, down from ¥508.5B in 1H2024
  • 2025-07-18Shiseido Americas announced 'significant' job cuts amid Drunk Elephant decline
  • 2025-03Restructured China and Travel Retail organizational structure
  • 2024-02-29Announced Mirai Shift NIPPON 2025 early retirement plan and ¥25B cost cuts
  • 2023-11Stock fell 14% in a single day amid China Fukushima-linked boycott
  • 2019Acquired Drunk Elephant for $845 million
  • 1872Founded by Arinobu Fukuhara as a pharmacy in Tokyo
Revision history
25 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
United Natural FoodsBest BuyMacy's
More in Retail and consumer conglomerates →
Sources